HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Heino, P. Articles by Dillner, J. Search for Related Content PubMed PubMed Citation Articles by Heino, P. Articles by Dillner, J. Agricola Articles by Heino, P. Articles by Dillner, J.

Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes

B. Skyldberg^2,

¹ The Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm S-171 77, Sweden
² Department of Cytology, Sabbatsberg Hospital, Stockholm, Sweden
³ Department of Chronic Viral Diseases, National Public Health Institute, Helsinki, Finland
⁴ Department of Pathology, University Central Hospital, Tampere, Finland
⁵ Departments of Pathology, Microbiology and Immunology, The Milton S. Hershey Medical Center, Hershey, USA
and⁶ Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, USA

The study of viral infectivity and detection of viral capsid antigens of the major cervical cancer-associated human papillomavirus (HPV) type, HPV-16, requires knowledge of which epitopes are exposed in clinical specimens of infected tissue or on intact capsids. To define the antigenic epitopes of HPV-16, antisera to 66 overlapping synthetic peptides corresponding to the HPV-16 capsid proteins L1 and L2 and to seven peptide analogues were tested in immunoperoxidase stainings of consecutive sections from formalin-fixed, paraffin-embedded HPV infected tissue. Antisera against eleven different peptides from L1 and against seven different peptides from L2 recognized the HPV capsid antigen. Most epitopes were only found on the capsid antigen of certain genital HPV types, but four antigenic epitopes in L1 were detectable also in cutaneous wart specimens. All antigenic epitopes in L2 were restricted to genital HPV types and four L2 epitopes were only detectable in HPV-16 or HPV-33 positive specimens. The surface exposure of the antigenic epitopes was investigated by comparing the reactivity of the antipeptide antisera with intact or disrupted virions or capsids of HPV-11, HPV-16 and bovine papillomavirus (BPV). Twenty antipeptide sera from L1 and seven antipeptide sera from L2 were reactive with intact HPV-16 capsids at titres up to 1:146000. Sixteen of these antisera were also reactive with disrupted HPV-16 capsids. Cross-reactivity with disrupted HPV-11 and BPV was detected for eleven and six antisera, respectively, whereas intact HPV-11 or BPV virions showed only weak cross-reactivity. In conclusion, the HPV-16 L1 and L2 capsid proteins contained multiple antigenic epitopes, most of which were shared with one or several additional HPV types.

^* Author for correspondence. Fax +46 8 326702. e-mail Joakim.Dillner@mtc.ki.se

Present address: Department of Medical Laboratory Technology, Stockholm University College of Health Sciences, Stockholm, Sweden.

Received 7 November 1994; accepted 13 December 1994.

This article has been cited by other articles:

				L. Rocha-Zavaleta, J. P. Ambrosio, M. d. L. Mora-Garcia, F. Cruz-Talonia, J. Hernandez-Montes, B. Weiss-Steider, V. Ortiz-Navarrete, and A. Monroy-Garcia Detection of antibodies against a human papillomavirus (HPV) type 16 peptide that differentiate high-risk from low-risk HPV-associated low-grade squamous intraepithelial lesions J. Gen. Virol., September 1, 2004; 85(9): 2643 - 2650. [Abstract] [Full Text] [PDF]

				X.-M. Wang, J. C. Cook, J. C. Lee, K. U. Jansen, N. D. Christensen, S. W. Ludmerer, and W. L. McClements Human papillomavirus type 6 virus-like particles present overlapping yet distinct conformational epitopes J. Gen. Virol., June 1, 2003; 84(6): 1493 - 1497. [Abstract] [Full Text] [PDF]

				R. Yang, P. M. Day, W. H. Yutzy IV, K.-Y. Lin, C.-F. Hung, and R. B. S. Roden Cell Surface-Binding Motifs of L2 That Facilitate Papillomavirus Infection J. Virol., March 15, 2003; 77(6): 3531 - 3541. [Abstract] [Full Text] [PDF]

				R. T. Emeny, C. M. Wheeler, K. U. Jansen, W. C. Hunt, T.-M. Fu, J. F. Smith, S. MacMullen, M. T. Esser, and X. Paliard Priming of Human Papillomavirus Type 11-Specific Humoral and Cellular Immune Responses in College-Aged Women with a Virus-Like Particle Vaccine J. Virol., June 27, 2002; 76(15): 7832 - 7842. [Abstract] [Full Text] [PDF]

				A.-L. Combita, A. Touze, L. Bousarghin, N. D. Christensen, and P. Coursaget Identification of Two Cross-Neutralizing Linear Epitopes within the L1 Major Capsid Protein of Human Papillomaviruses J. Virol., June 5, 2002; 76(13): 6480 - 6486. [Abstract] [Full Text] [PDF]

				M. M. Okun, P. M. Day, H. L. Greenstone, F. P. Booy, D. R. Lowy, J. T. Schiller, and R. B. S. Roden L1 Interaction Domains of Papillomavirus L2 Necessary for Viral Genome Encapsidation J. Virol., May 1, 2001; 75(9): 4332 - 4342. [Abstract] [Full Text]

				I. Silins, Z. Wang, B. Frankendal, U. Vikmanis, M. Sapp, J. T. Schiller, and J. Dillner Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis J. Gen. Virol., November 1, 1999; 80(11): 2931 - 2936. [Abstract] [Full Text]

				L Kjellberg, Z Wang, F Wiklund, K Edlund, T Angstrom, P Lenner, I Sjoberg, G Hallmans, K. Wallin, M Sapp, et al. Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study J. Gen. Virol., February 1, 1999; 80(2): 391 - 398. [Abstract]